Webinar: BREXIT – Impact on Clinical Trials Being Run in the UK

In this webinar, our expert presenter covers vital and timely information, as the United Kingdom’s (UK) departure date from the European Union (EU) fast approaches.

Topics include:
• Changes for new studies
• Implications for ongoing studies
• IMP importation and guidance
• How to register for the Medicines and Healthcare products Regulatory Agency (MHRA) submissions portal

A question and answer section follows at the end.

Our expert speaker: Louise Bracewell, BSc. Senior Regulatory Affairs Manager, Ergomed
Louise has over 12 years of experience in the field of Regulatory Affairs, managing and supporting multi-national Phase II-IV studies, in a variety of indications, through regulatory affairs processes from initial applications to CSR submission. Louise also comes with 12-plus years of experience in submitting clinical trials to the MHRA and Research Ethics Committees in the UK.